{
    "nct_id": "NCT03061474",
    "title": "A Double-Blind-Randomized, Placebo-Controlled Adaptive Design Trial of Nicotinamide in Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease Dementia",
    "status": "COMPLETED",
    "last_update_time": "2023-09-22",
    "description_brief": "The purpose of this research study is to test whether nicotinamide, also known as vitamin B3 or niacinamide, taken in high doses, can reduce phosphorylation of tau (the protein that accumulates in neurofibrillary tangles) in people with Mild Cognitive Impairment or mild Alzheimer's disease (AD) dementia.",
    "description_detailed": "Nicotinamide, the amide of nicotinic acid (vitamin B3/niacin), is an oral therapy with a wealth of clinical data in a variety of therapeutic areas, including preliminary data supporting its safety in Alzheimer's disease (AD). Preclinical work in a mouse model that develops both plaques and tangles supports the hypothesis that nicotinamide can act as a histone deacetylase (HDAC) inhibitor to reduce phosphorylation of tau.\n\nThe study will implement a group sequential design, incorporating a futility analysis with a go/no-go decision conditional on cerebral spinal fluid CSF biomarker outcomes at 12-months. The primary outcome for the trial is change in p-tau231.\n\nThis study timeline includes a screening phase of up to 60 days and treatment phase which is expected to last about 48 weeks and will include 4 study visits.\n\nAn additional 12-month treatment and follow-up period is planned, contingent upon a \"go\" decision based on the primary outcome (CSF p-tau231) or one planned secondary outcome (CSF p-tau181)",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "recruitmentDetails": "46 participants received at least 1 dose of study drug.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "Nicotinamide",
                    "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "24"
                                },
                                {
                                    "groupId": "FG001",
                                    "comment": "22 participants received treatment therapy.",
                                    "numSubjects": "22"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "22"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "18"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Safety Risk",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Participant unwilling or unable to participate",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "2"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Nicotinamide",
                    "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "24"
                        },
                        {
                            "groupId": "BG001",
                            "value": "22"
                        },
                        {
                            "groupId": "BG002",
                            "value": "46"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "74.56",
                                            "spread": "8.97"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "72.92",
                                            "spread": "744"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "73.78",
                                            "spread": "8.23"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "20"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "14"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "26"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "2"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "44"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "42"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "46"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Mini-Mental State Examination",
                    "description": "The Mini-Mental State Examination is a brief mental status exam and widely used dementia screening instrument. It evaluates orientation to time and place, memory, attention, language, and visuospatial ability. Range: 0-30; a lower score indicates greater impairment.",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "25.62",
                                            "spread": "2.87"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "25.5",
                                            "spread": "3.22"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "25.57",
                                            "spread": "3.01"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change in P-tau 231",
                    "description": "Change in key peptide in cerebrospinal fluid (CSF) from baseline to 48 weeks. Higher phosphorylated tau (p-tau) is associated with a severity of Alzheimer's disease pathology.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4.71",
                                            "spread": "14.46"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.28",
                                            "spread": "10.55"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.6096",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Vital Signs - Weight",
                    "description": "Weight in kg was recorded at every study visit (screening, baseline, week 12, week 24, and week 48)",
                    "populationDescription": "Numbers analyzed in some rows lower due to missing data (visit not completed, or participant refused measure).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "kg",
                    "timeFrame": "Screening through end of study (week 48)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Screening Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "76.39",
                                            "spread": "12.99"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "68.11",
                                            "spread": "14.3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "76.29",
                                            "spread": "12.57"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "70.05",
                                            "spread": "11.86"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "77.27",
                                            "spread": "10.86"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "69.36",
                                            "spread": "12.67"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 24 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "76.88",
                                            "spread": "11.49"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "72.22",
                                            "spread": "11.35"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 48 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "76.43",
                                            "spread": "11.96"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "70.27",
                                            "spread": "12.2"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Vital Signs - BMI",
                    "description": "Body Mass Index (BMI) was recorded at every study visit (screening, baseline, week 12, week 24, and week 48)",
                    "populationDescription": "Numbers analyzed in some rows lower due to missing data (visit not completed, or participant refused measure).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "kg/m^2",
                    "timeFrame": "Screening through end of study (week 48)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Screening Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.35",
                                            "spread": "4.75"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.09",
                                            "spread": "4.17"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.33",
                                            "spread": "4.69"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.85",
                                            "spread": "3.43"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.42",
                                            "spread": "4.51"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.72",
                                            "spread": "3.79"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 24 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.52",
                                            "spread": "4.56"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "25.08",
                                            "spread": "3.68"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 48 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "26.24",
                                            "spread": "4.75"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "24.68",
                                            "spread": "3.68"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Vital Signs - Systolic Blood Pressure",
                    "description": "Systolic blood pressure was recorded at every study visit (screening, baseline, week 12, week 24, and week 48)",
                    "populationDescription": "Numbers analyzed in some rows lower due to missing data (visit not completed, or participant refused measure).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "mm Hg",
                    "timeFrame": "Screening through end of study (week 48)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Screening Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "134.67",
                                            "spread": "19.17"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "126.09",
                                            "spread": "14.32"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "137.42",
                                            "spread": "15.99"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "125.41",
                                            "spread": "17.66"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "133.36",
                                            "spread": "14.91"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "128.05",
                                            "spread": "18.61"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 24 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "130.4",
                                            "spread": "14.04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "130.16",
                                            "spread": "13.12"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 48 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "129.43",
                                            "spread": "17.76"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "129.37",
                                            "spread": "17.16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Vital Signs - Diastolic Blood Pressure",
                    "description": "Diastolic blood pressure was recorded at every study visit (screening, baseline, week 12, week 24, and week 48)",
                    "populationDescription": "Numbers analyzed in some rows lower due to missing data (visit not completed, or participant refused measure).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "mm Hg",
                    "timeFrame": "Screening through end of study (week 48)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Screening Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "75.42",
                                            "spread": "9.31"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "71.32",
                                            "spread": "8.97"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "74.21",
                                            "spread": "11.87"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "70.45",
                                            "spread": "8.78"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "72.45",
                                            "spread": "7.61"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "71.4",
                                            "spread": "10.23"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 24 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "75.2",
                                            "spread": "7.35"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "71.4",
                                            "spread": "10.23"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 48 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "71.9",
                                            "spread": "10.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "69.74",
                                            "spread": "8.53"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Vital Signs - Pulse",
                    "description": "Pulse rate was recorded at every study visit (screening, baseline, week 12, week 24, and week 48)",
                    "populationDescription": "Numbers analyzed in some rows lower due to missing data (visit not completed, or participant refused measure).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "bpm",
                    "timeFrame": "Screening through end of study (week 48)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Screening Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "56.42",
                                            "spread": "6.98"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "62.5",
                                            "spread": "10.92"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Baseline Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "22"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "59.33",
                                            "spread": "12.85"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "64.91",
                                            "spread": "8.78"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 12 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "22"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "58.86",
                                            "spread": "6.14"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "63.45",
                                            "spread": "11.65"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 24 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "20"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "58.6",
                                            "spread": "7.42"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "62.26",
                                            "spread": "8.75"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Week 48 Visit",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "21"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "19"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "59.57",
                                            "spread": "8.33"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "64.84",
                                            "spread": "12.65"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Count of Treatment Emergent Adverse Events",
                    "description": "Count of treatment emergent adverse events (TEAEs) over the duration of the study period (baseline to 48 weeks).",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "events",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "79"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "71"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Count of Adverse Events by Severity",
                    "description": "Count of treatment emergent adverse events (TEAEs) over the duration of the study period (baseline to 48 weeks).",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "events",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Mild",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "49"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "38"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Moderate",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "27"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "31"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Severe",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Total",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "79"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "71"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Columbia-Suicide Severity Rating Scale",
                    "description": "The Columbia-Suicide Severity Rating Scale (C-SSRS) captures the occurrence, severity, and frequency of suicide-related thoughts and behaviors during the corresponding assessment period. The scale includes suggested questions to elicit the type of information needed to determine if a suicide-related thought or behavior occurred. The number and proportion of subjects with treatment emergent Suicidal ideation or behavior during the study period of (baseline to week 48) will be reported overall and by study arm. Treatment emergent suicidal ideation or behavior is defined as a \"yes\" answer at any time during treatment to any one of the questions in the ten suicidal ideation and behavior categories (Categories 1- 10) on the C-SSRS. Self-injurious behavior without suicidal intent, while assessed on the C-SSRS, does not form part of this outcome.",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "events",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "Baseline Number of abnormal C-SSRS events",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "Post-baseline number of abnormal C-SSRS events",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "3"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "ECG Abnormalities",
                    "description": "Count of participants experiencing at least one electrocardiogram (ECG) abnormality.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "24"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "20"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in ab40",
                    "description": "Change in key peptide in cerebrospinal fluid (CSF) from baseline to 48 weeks. Lower ab40 is associated with a greater probability of fibrillar amyloid burden in the brain.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2307",
                                            "spread": "2516.4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1961.1",
                                            "spread": "4252.97"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.648",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in ab42",
                    "description": "Change in key peptide in cerebrospinal fluid (CSF) from baseline to 48 weeks. Lower ab42 is associated with a greater probability of fibrillar amyloid burden in the brain.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "127.74",
                                            "spread": "161.54"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "113.79",
                                            "spread": "321.92"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.6833",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in P-tau 181",
                    "description": "Change in key peptide in cerebrospinal fluid (CSF) from baseline to 48 weeks. Higher total value is associated with greater severity of Alzheimer's disease pathology.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.41",
                                            "spread": "29.83"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-10.43",
                                            "spread": "41.79"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.4438",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Total Tau",
                    "description": "Change in CSF total tau in individuals with mild Alzheimer's disease (AD) dementia or Mild Cognitive Impairment due to AD.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "pg/ml",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-8.42",
                                            "spread": "228.59"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-60.47",
                                            "spread": "237.54"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.7158",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Ratio of Total Tau/ab40",
                    "description": "Change in ratio of key peptides in cerebrospinal fluid (CSF) from baseline to 48 weeks. A lower ab40/tau ratio is associated with a higher risk of dementia.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ratio",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.02",
                                            "spread": "0.02"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.02",
                                            "spread": "0.02"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.93428359",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in Ratio of Total Tau/ab42",
                    "description": "Change in ratio of key peptides in cerebrospinal fluid (CSF) from baseline to 48 weeks. A lower ab42/tau ratio is associated with a higher risk of dementia.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ratio",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "19"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "19"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-0.46",
                                            "spread": "0.56"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.5",
                                            "spread": "0.55"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.9931",
                            "statisticalMethod": "ANCOVA"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "ADASCog-13",
                    "description": "ADAS-Cog13 is a structured scale that evaluates memory (immediate and delayed word recall; immediate word recognition), receptive and expressive language, orientation, ideational praxis (preparing a letter for mailing), constructional praxis (copying figures), and attention (number cancellation). Ratings of spoken language, language comprehension, word finding difficulty, and ability to remember test instructions also are obtained. Range: 0-85; higher scores indicate greater impairment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "3.2",
                                            "spread": "5.72"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "5.16",
                                            "spread": "7.46"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3233",
                            "statisticalMethod": "Mixed Models Analysis"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Activities of Daily Living - Mild Cognitive Impairment",
                    "description": "The ADCS-ADL-MCI is a measure of patient functional performance in Alzheimer's Disease and Mild Cognitive Impairment trials. The informant-based questionnaire assesses conduct of basic and instrumental Activities of Daily Living (ADLs). A total of 24 ADLs are evaluated. Scores range from 0 to 53, with higher scores representing more maintained function.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "20"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-4.05",
                                            "spread": "4.88"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-1.39",
                                            "spread": "6.06"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.1008",
                            "statisticalMethod": "Mixed Models Analysis"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "CDR Sum of Boxes",
                    "description": "CDR-SB is a composite rating of cognition and everyday function which incorporates both informant input and direct assessment of performance. It assesses through semi-structured interview three cognitive domains (memory, orientation, and judgement/problem solving) and three everyday functional domains (community affairs, home and hobbies, personal care). Level of impairment in each of the six domains is rated from none (score=0) to severe (score=3). The six domain scores are then summed to create the CDR-SB. Range 0-18; higher scores indicate greater impairment.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "score on a scale",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "21"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "20"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.76",
                                            "spread": "2.03"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.18",
                                            "spread": "2.82"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.0323",
                            "statisticalMethod": "Mixed Models Analysis"
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "QTC Abnormalities",
                    "description": "Count of participants experiencing at least one electrocardiogram (ECG) QT interval abnormality. Abnormal defined as above 460 for men and above 470 for women.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "24"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "22"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change in QTC",
                    "description": "Average within-subject change in electrocardiogram QT interval.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "ms",
                    "timeFrame": "Baseline to 48 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Nicotinamide",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet."
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "22"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "21"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "6.41",
                                            "spread": "16.02"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "2.1",
                                            "spread": "11.85"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Adverse event data were collected from signed consent through the participant duration in the study. The specific time period is from consent through the end of the 48 week double-blind trial. Adverse event information will be collected at every planned and unplanned in-person and telephone visit until 7 (for non-serious AEs) or 30 days (for SAEs) after the last day of study participation.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Nicotinamide",
                    "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nNicotinamide: Niacinamide (nicotinamide; 99%) is produced in a 750 mg sustained release tablet.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 24,
                    "seriousNumAffected": 2,
                    "seriousNumAtRisk": 24,
                    "otherNumAffected": 23,
                    "otherNumAtRisk": 24
                },
                {
                    "id": "EG001",
                    "title": "Placebo",
                    "description": "1500mg twice daily: 2, 750mg tablets taken orally twice daily\n\nPlacebo Comparator: Oral Tablet",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 22,
                    "seriousNumAffected": 6,
                    "seriousNumAtRisk": 22,
                    "otherNumAffected": 20,
                    "otherNumAtRisk": 22
                }
            ],
            "seriousEvents": [
                {
                    "term": "Leukocytosis",
                    "organSystem": "Blood and lymphatic system disorders",
                    "sourceVocabulary": "MedDRA",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Transaminases increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dehydration",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Colorectal cancer",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Seizure",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dyspnea",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Orthostatic hypotension",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Thrombocytopenia",
                    "organSystem": "Blood and lymphatic system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Retinal detachment",
                    "organSystem": "Eye disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Abdominal discomfort",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Colitis ulcerative",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Constipation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Diarrhoea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 8,
                            "numAffected": 6,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dyspepsia",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Eructation",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Hiatus hernia",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Neusea",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Rectal haemorrhage",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Vomiting",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Fatigue",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 3,
                            "numAffected": 3,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Corona virus infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Diverticulitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Fungal infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Gastritis viral",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Hordeolum",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Pneumonia",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Pyuria",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Tooth abscess",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Upper respiratory tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Urinary tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 4,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 5,
                            "numAffected": 4,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Viral upper respiratory tract infection",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 4,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Fibula fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Foot fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Hand fracture",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Head Injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Laceration",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Limb injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Post lumbar puncture syndrome",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Antimitochondrial antibody positive",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Aspartate aminotransferase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Blood alkaline phosphatase increased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Blood testosterone decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Glomerular Ffiltration rate decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Laboratory test abnormal",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Urine ketone body present",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Weight decreased",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dehydration",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Diabetes mellitus",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Hyperlipidaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Hypokalaemia",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Vitamin D deficiency",
                    "organSystem": "Metabolism and nutrition disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Arthralgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Arthritis",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Coccydynia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Foot deformity",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Myalgia",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Osteoporosis",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Pain in extremity",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Basal cell carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Squamous cell carcinoma",
                    "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Cognitive disorder",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dizziness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dysgeusia",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Memory impairment",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Neuropathy peripheral",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Parkinson's disease",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Pleocytosis",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Postural tremor",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Presyncope",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Syncoper",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Tremor",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Agitation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Anxiety",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Depression",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Parasomnia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Haematuria",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Micturition urgency",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Renal cyst",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Urinary incontinence",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Urinary retention",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Dyspnoea exertional",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Actinic keratosis",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Miliaria",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Penile ulceration",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Psoriasis",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Rash",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Urticaria",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Cancer surgery",
                    "organSystem": "Surgical and medical procedures",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Cataract operation",
                    "organSystem": "Surgical and medical procedures",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Skin neoplasm excision",
                    "organSystem": "Surgical and medical procedures",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Haemorrhage",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                },
                {
                    "term": "Labile blood pressure",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 20.0",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 24
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 22
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": true
            },
            "pointOfContact": {
                "title": "Dr. Joshua Grill",
                "organization": "University of California, Irvine",
                "email": "jgrill@uci.edu",
                "phone": "(949) 824-5905"
            }
        }
    },
    "target_category": "disease-targeted small molecule",
    "drug": [
        "nicotinamide (vitamin B3, niacinamide)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests high\u2011dose nicotinamide (vitamin B3/niacinamide) with the stated purpose of reducing tau phosphorylation (p\u2011tau231) in people with MCI or mild AD \u2014 i.e., it is intended to act on Alzheimer\u2019s pathology (tau). \ue200cite\ue202turn0search0\ue201",
        "Mechanism / classification: Nicotinamide is a small\u2011molecule NAD+ precursor and competitive inhibitor of class III histone deacetylases (sirtuins); preclinical work shows it selectively reduces tau phosphorylation (e.g., Thr231) via sirtuin/HDAC\u2011related pathways. These properties identify it as a disease\u2011targeted small molecule rather than a biologic or purely symptomatic cognitive enhancer. \ue200cite\ue202turn0search1\ue202turn0search5\ue201",
        "Act (extracted trial details): Trial title and description: double\u2011blind, randomized, placebo\u2011controlled adaptive trial of nicotinamide in MCI due to AD and mild AD dementia, with primary biomarker endpoint CSF p\u2011tau231. The investigational agent is nicotinamide (high\u2011dose oral). \ue200cite\ue202turn0search0\ue201",
        "Trial outcome note (relevant to interpretation): A published phase 2a randomized trial reported that nicotinamide was safe but did not significantly lower CSF p\u2011tau231 versus placebo after 48 weeks (no biomarker benefit observed). This does not change the intended target classification (pathology\u2011directed small molecule). \ue200cite\ue202turn0search0\ue202turn0search5\ue201",
        "Reflect: Given the intervention (small\u2011molecule vitamin) and its explicit aim to reduce tau phosphorylation (a core AD pathology), the correct category is 'disease\u2011targeted small molecule'. There is little ambiguity \u2014 the agent is not a biologic (e.g., antibody), not described as only symptomatic/cognitive enhancement without pathology targeting, nor focused on neuropsychiatric symptom management. \ue200cite\ue202turn0search1\ue202turn0search0\ue201"
    ],
    "agent_type": "B) Tau",
    "explanation_agent": [
        "Reason: The trial tests high\u2011dose nicotinamide (oral vitamin B3/niacinamide) with the explicit goal of reducing tau phosphorylation (CSF p\u2011tau231), i.e., it is intended to act on tau pathology rather than amyloid or purely symptomatic targets. \ue200cite\ue202turn0search0\ue202turn0search3\ue201",
        "Act: Extracted trial details \u2014 randomized, double\u2011blind, placebo\u2011controlled phase 2a of nicotinamide (1,500 mg twice daily; 3,000 mg/day) in MCI/mild AD with primary biomarker endpoint CSF p\u2011tau231; the investigational agent is a small\u2011molecule vitamin that in preclinical models reduces Thr231\u2011phospho\u2011tau via sirtuin (class III HDAC) inhibition. \ue200cite\ue202turn0search0\ue202turn0search3\ue202turn0search2\ue201",
        "Reflect: Classifying under CADRO, the most specific fit is B) Tau because the intervention is disease\u2011targeted at tau phosphorylation (not a biologic anti\u2011tau antibody, nor a symptomatic neurotransmitter agent), and the trial\u2019s stated mechanism and primary biomarker are tau\u2011focused. Although nicotinamide is a small molecule and has broader metabolic effects (NAD+ related), the trial\u2019s explicit pathology target (p\u2011tau231) makes B) Tau the correct CADRO category. \ue200cite\ue202turn0search3\ue202turn0search0\ue201",
        "Web search results (key sources used): PubMed phase\u20112a trial reporting primary endpoint CSF p\u2011tau231 and that nicotinamide was safe but did not significantly alter AD biomarkers after 48 weeks. \ue200cite\ue202turn0search0\ue201; Preclinical 3xTg\u2011AD mouse study showing nicotinamide acts via sirtuin inhibition and selectively reduces Thr231\u2011phospho\u2011tau. \ue200cite\ue202turn0search3\ue201; ClinicalTrials registry/registry summary for NCT03061474 confirming trial design, dose, and primary biomarker endpoint. \ue200cite\ue202turn0search2\ue201"
    ]
}